SGLT2i Dapagliflozin in primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy +/- trastuzumab: rationale and design of the multicenter PROTECT trial
Authors
Fernando Guerra (ORCID: https://orcid.org/0000-0001-8780-9379)
Giuseppina Uccello
Lorenzo Perrone (ORCID: https://orcid.org/0000-0001-5273-9788)
Laura Scelsi (ORCID: https://orcid.org/0000-0001-9409-691X)
Chemotherapy-induced cardiotoxicity and mitigation
Type
article
Field-Weighted Citation Impact
2.78
Funders
Ministero della Salute
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
SGLT2i Dapagliflozin in primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy +/- trastuzumab: rationale and design of the multicenter PROTECT trial
Fernando Guerra, Giuseppina Uccello, Lorenzo Perrone, Laura Scelsi et al.
Citations
2 citations
Journal
Cardio-Oncology
Topics
Chemotherapy-induced cardiotoxicity and mitigation
Field-Weighted Citation Impact (FWCI)
2.78
article
SGLT2i Dapagliflozin in primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy +/- trastuzumab: rationale and design of the multicenter PROTECT trial
Fernando Guerra, Giuseppina Uccello, Lorenzo Perrone, Laura Scelsi, A. Paccone, Alessandra Greco, Vincenzo Quagliariello, Sandra Schirinzi, Stefano Ghio, Catherine Klersy, Stefano Oliva, Nicola Maurea, Mauro Acquaro, Andrea Tedeschi, M. C. Galiazzo, Maria Laura Canale, Annalisa Turco, M. De Amicis, L. De Luca, Gianpiero Rizzo
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
Cardio-OncologyVol. 11(1)
Institutions
Marche Polytechnic University (IT), Alessandro Manzoni Hospital (IT), Istituto Tumori Bari (IT), Guglielmo da Saliceto Hospital (IT), Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT), Policlinico San Matteo Fondazione (IT), Ospedale Versilia (IT)
Funders
Ministero della Salute
OpenAlex Percentile
Openalex Percentile: Top 8%
Topics
Chemotherapy-induced cardiotoxicity and mitigation